Affiliations 

  • 1 School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
  • 2 Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, China
  • 3 Institute of Systems Biology, Universiti Kebangsaan Malaysia, Bangi, Malaysia
  • 4 Affiliated Taihe Hospital of Chinese Medicine, Anhui University of Chinese Medicine, Taihe, China
  • 5 School of Life Sciences, Anhui University of Chinese Medicine, Hefei, China
Front Pharmacol, 2024;15:1288584.
PMID: 38500762 DOI: 10.3389/fphar.2024.1288584

Abstract

Objective: To evaluate the efficacy of the fruits of the medicinal plant Forsythia suspensa (Thunb.) Vahl (FS), in treating inflammation-associated diseases through a meta-analysis of animal models, and also probe deeply into the signaling pathways underlying the progression of inflammation. Materials and methods: All data analyses were performed using Review Manager 5.3 and the results are presented as flow diagrams, risk-of-bias summaries, forest plots, and funnel plots. Summary estimates were calculated using a random- or fixed-effect model, depending on the value of I2. Results: Of the 710 records identified in the initial search, 11 were selected for the final meta-analysis. Each study extracted data from the model and treatment groups for analysis, and the results showed that FS alleviated the inflammatory cytokine levels in serum; oxidant indicator: reactive oxygen species; enzymes of liver function; endotoxin and regulatory cells in blood; and improved the antioxidant enzyme superoxide dismutase. Conclusion: FS effectively reversed the change in acute or chronic inflammation indicators in animal models, and the regulation of multiple channel proteins in inflammatory signaling pathways suggests that FS is a good potential drug for inflammatory disease drug therapy.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.